Lynestrenol

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Progestin derivative.

Half-lifeThis section has been translated automatically.

17–21 h

IndicationThis section has been translated automatically.

Secondary amenorrhoea, endometriosis, dysfunctional bleeding, as a "mini pill" or in combination with an estrogen for oral contraception.

Dosage and method of useThis section has been translated automatically.

In combination with an oestrogen from the 16th to 25th day of the cycle 5 mg/day p.o. or as a mono-preparation ("minipill") continuous intake from the 1st day of the cycle of 0.5 mg/day p.o.

Undesirable effectsThis section has been translated automatically.

Cholelithiasis, candidiasis, extrauterine pregnancy, see also gestagens.

InteractionsThis section has been translated automatically.

If barbiturates, carbamazepine, griseofulvin, phenytoin, proxibarbital and rifampicin are taken at the same time, the contraceptive protection of the "minipill" is impaired.

PreparationsThis section has been translated automatically.

Orgametril

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer